Synergistic stimulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities by retinoic acid and astroglial factors in immortalized rat brain microvessel endothelial cells.
The immortalized rat brain microvessel endothelial cell line RBE4 was used to investigate the in vitro regulation of two blood-brain barrier specific enzymes, gamma-glutamyl transpeptidase (GTP) and alkaline phosphatase (ALP). The effects of bFGF, astroglial factors, and retinoic acid (a cell differentiation agent) on GTP and ALP activities were separately or simultaneously studied in order to define optimal culture conditions for induction of these two specific enzymes of the blood-brain barrier. In the present study, a phenotypically distinct subpopulation of endothelial cells has been shown to develop from confluent cobblestone monolayers of RBE4 immortalized cerebral endothelial cells. These distinct cells were present within multicellular aggregates and specifically exhibited GTP and ALP activities. Addition of bFGF, astroglial factors, or retinoic acid induced the formation of these three-dimensional structures and in consequence an increase in GTP and ALP activities. For retinoic acid and astroglial factors, this increase could also be explained by the stimulation of either GTP or ALP expression in the phenotypically distinct positive cells associated with aggregates. Simultaneous treatment with retinoic acid and astroglial factors had a synergistic effect on GTP and ALP expression and thus may allow these distinct cells to evolve toward a more differentiated state. Since such results were also obtained with physiological concentrations of retinoic acid, we suggest that addition of this agent might contribute to greater differentiation of cells in in vitro blood-brain barrier models where endothelial cells are cocultured with astrocytes.
el Hafny
B
B
INSERM U26, Unité de Neuro-Pharmaco-Nutrition, Hôpital F. Widal, Paris, France.
Bourre
J M
JM
Roux
F
F
D000469:Alkaline Phosphatase / Q000378:metabolism*; D000818:Animals; D001253:Astrocytes / Q000378:metabolism*; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000502:physiology*; D001921:Brain / Q000098:blood supply; D002460:Cell Line; D017077:Culture Media, Conditioned; D004357:Drug Synergism; D004730:Endothelium, Vascular / Q000187:drug effects / Q000201:enzymology*; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D006651:Histocytochemistry; D008858:Microscopy, Phase-Contrast; D051381:Rats; D014212:Tretinoin / Q000494:pharmacology*; D005723:gamma-Glutamyltransferase / Q000378:metabolism*
D017077:Culture Media, Conditioned; D016222:Fibroblast Growth Factor 2; D014212:Tretinoin; D005723:gamma-Glutamyltransferase; D000469:Alkaline Phosphatase